Advocacy at a Glance STEVEN GROSSMAN 6/9/17 Advocacy at a Glance STEVEN GROSSMAN 6/9/17 Questions About FDA and the Federal Budget and more Read More Analysis and Commentary STEVEN GROSSMAN 5/31/17 Analysis and Commentary STEVEN GROSSMAN 5/31/17 How the Federal Budget Applies to the FDA -- A Refresher for FY 18 Read More Advocacy at a Glance STEVEN GROSSMAN 5/31/17 Advocacy at a Glance STEVEN GROSSMAN 5/31/17 FDA In the Context of the Federal Budget and more Read More Analysis and Commentary STEVEN GROSSMAN 5/26/17 Analysis and Commentary STEVEN GROSSMAN 5/26/17 The Good News; the Bad News; and What's Next? Read More Advocacy at a Glance STEVEN GROSSMAN 5/26/17 Advocacy at a Glance STEVEN GROSSMAN 5/26/17 New FDA Commissioner Testifies and more Read More STEVEN GROSSMAN 5/23/17 STEVEN GROSSMAN 5/23/17 President Trump's FY 18 Budget Request Threatens FDA's Mission Read More Advocacy at a Glance STEVEN GROSSMAN 5/19/17 Advocacy at a Glance STEVEN GROSSMAN 5/19/17 How a 6% Budget Increase Can Actually Be a 45% Decrease Read More Advocacy at a Glance STEVEN GROSSMAN 5/19/17 Advocacy at a Glance STEVEN GROSSMAN 5/19/17 New FDA Commissioner Scott Gottlieb Read More Analysis and Commentary STEVEN GROSSMAN 5/12/17 Analysis and Commentary STEVEN GROSSMAN 5/12/17 Proposed FDA FY 18 Budget Swap a Non-Starter Read More Advocacy at a Glance STEVEN GROSSMAN 5/12/17 Advocacy at a Glance STEVEN GROSSMAN 5/12/17 President’s Full Budget Release Set for May 23 and more Read More Analysis and Commentary STEVEN GROSSMAN 5/5/17 Analysis and Commentary STEVEN GROSSMAN 5/5/17 Time for Some Heartfelt "Thank you"s Read More Advocacy at a Glance STEVEN GROSSMAN 5/5/17 Advocacy at a Glance STEVEN GROSSMAN 5/5/17 FY 17 Omnibus Becomes Law; Brings Funding Support for FDA and more Read More Analysis and Commentary STEVEN GROSSMAN 4/28/17 Analysis and Commentary STEVEN GROSSMAN 4/28/17 Success ... But More Work Will Be Needed! Read More Advocacy at a Glance STEVEN GROSSMAN 4/28/17 Advocacy at a Glance STEVEN GROSSMAN 4/28/17 Alliance Capitol Hill Advocacy Day is a Success and more Read More Advocacy at a Glance STEVEN GROSSMAN 4/21/17 Advocacy at a Glance STEVEN GROSSMAN 4/21/17 Alliance Hill Day Read More Analysis and Commentary STEVEN GROSSMAN 4/21/17 Analysis and Commentary STEVEN GROSSMAN 4/21/17 Now Is the Time for YOU to Take Action, PLEASE Read More Analysis and Commentary STEVEN GROSSMAN 4/14/17 Analysis and Commentary STEVEN GROSSMAN 4/14/17 Congress Doesn't "Dispose" in a Vacuum Read More Advocacy at a Glance STEVEN GROSSMAN 4/14/17 Advocacy at a Glance STEVEN GROSSMAN 4/14/17 Alliance Has Thoughtful Discussion with OMB and more Read More Analysis and Commentary STEVEN GROSSMAN 4/7/17 Analysis and Commentary STEVEN GROSSMAN 4/7/17 Help Us to Deliver Some Specific Messages to Congress Read More Advocacy at a Glance STEVEN GROSSMAN 4/7/17 Advocacy at a Glance STEVEN GROSSMAN 4/7/17 Focus on FDA’s Workplace Needs and more Read More Newer Posts Older Posts
Advocacy at a Glance STEVEN GROSSMAN 6/9/17 Advocacy at a Glance STEVEN GROSSMAN 6/9/17 Questions About FDA and the Federal Budget and more Read More
Analysis and Commentary STEVEN GROSSMAN 5/31/17 Analysis and Commentary STEVEN GROSSMAN 5/31/17 How the Federal Budget Applies to the FDA -- A Refresher for FY 18 Read More
Advocacy at a Glance STEVEN GROSSMAN 5/31/17 Advocacy at a Glance STEVEN GROSSMAN 5/31/17 FDA In the Context of the Federal Budget and more Read More
Analysis and Commentary STEVEN GROSSMAN 5/26/17 Analysis and Commentary STEVEN GROSSMAN 5/26/17 The Good News; the Bad News; and What's Next? Read More
Advocacy at a Glance STEVEN GROSSMAN 5/26/17 Advocacy at a Glance STEVEN GROSSMAN 5/26/17 New FDA Commissioner Testifies and more Read More
STEVEN GROSSMAN 5/23/17 STEVEN GROSSMAN 5/23/17 President Trump's FY 18 Budget Request Threatens FDA's Mission Read More
Advocacy at a Glance STEVEN GROSSMAN 5/19/17 Advocacy at a Glance STEVEN GROSSMAN 5/19/17 How a 6% Budget Increase Can Actually Be a 45% Decrease Read More
Advocacy at a Glance STEVEN GROSSMAN 5/19/17 Advocacy at a Glance STEVEN GROSSMAN 5/19/17 New FDA Commissioner Scott Gottlieb Read More
Analysis and Commentary STEVEN GROSSMAN 5/12/17 Analysis and Commentary STEVEN GROSSMAN 5/12/17 Proposed FDA FY 18 Budget Swap a Non-Starter Read More
Advocacy at a Glance STEVEN GROSSMAN 5/12/17 Advocacy at a Glance STEVEN GROSSMAN 5/12/17 President’s Full Budget Release Set for May 23 and more Read More
Analysis and Commentary STEVEN GROSSMAN 5/5/17 Analysis and Commentary STEVEN GROSSMAN 5/5/17 Time for Some Heartfelt "Thank you"s Read More
Advocacy at a Glance STEVEN GROSSMAN 5/5/17 Advocacy at a Glance STEVEN GROSSMAN 5/5/17 FY 17 Omnibus Becomes Law; Brings Funding Support for FDA and more Read More
Analysis and Commentary STEVEN GROSSMAN 4/28/17 Analysis and Commentary STEVEN GROSSMAN 4/28/17 Success ... But More Work Will Be Needed! Read More
Advocacy at a Glance STEVEN GROSSMAN 4/28/17 Advocacy at a Glance STEVEN GROSSMAN 4/28/17 Alliance Capitol Hill Advocacy Day is a Success and more Read More
Advocacy at a Glance STEVEN GROSSMAN 4/21/17 Advocacy at a Glance STEVEN GROSSMAN 4/21/17 Alliance Hill Day Read More
Analysis and Commentary STEVEN GROSSMAN 4/21/17 Analysis and Commentary STEVEN GROSSMAN 4/21/17 Now Is the Time for YOU to Take Action, PLEASE Read More
Analysis and Commentary STEVEN GROSSMAN 4/14/17 Analysis and Commentary STEVEN GROSSMAN 4/14/17 Congress Doesn't "Dispose" in a Vacuum Read More
Advocacy at a Glance STEVEN GROSSMAN 4/14/17 Advocacy at a Glance STEVEN GROSSMAN 4/14/17 Alliance Has Thoughtful Discussion with OMB and more Read More
Analysis and Commentary STEVEN GROSSMAN 4/7/17 Analysis and Commentary STEVEN GROSSMAN 4/7/17 Help Us to Deliver Some Specific Messages to Congress Read More
Advocacy at a Glance STEVEN GROSSMAN 4/7/17 Advocacy at a Glance STEVEN GROSSMAN 4/7/17 Focus on FDA’s Workplace Needs and more Read More
